Evidence map›Paper›PMID 21365281›Full record

ArticleCellular and molecular life sciences : CMLS2011

The sheddase activity of ADAM17/TACE is regulated by the tetraspanin CD9.

Maria Dolores Gutiérrez-López, Alvaro Gilsanz, María Yáñez-Mó, Susana Ovalle, Esther M Lafuente, Carmen Domínguez, Peter N Monk, Isidoro González-Alvaro, Francisco Sánchez-Madrid, Carlos Cabañas

Open access · greenAbstract read
In one paragraph

Article in Cellular and molecular life sciences : CMLS, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 100 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. CD9, a tetraspanin target for cancer therapy?Experimental biology and medicine (Maywood, N.J.) · 2021
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 2 countries.

Maria Dolores Gutiérrez-LópezCentro de Biología Molecular Severo Ochoa (CSIC-UAM), Nicolás Cabrera 1, Campus de Cantoblanco, 28049 Madrid, Spain.
Alvaro Gilsanz
María Yáñez-Mó
Susana Ovalle
Esther M Lafuente
Carmen Domínguez
Peter N Monk
Isidoro González-Alvaro
Francisco Sánchez-Madrid
Carlos Cabañas
Hospital Universitario de La Princesa · ESUniversidad Autónoma de Madrid · ESCentro de Biología Molecular Severo Ochoa · ESSpanish National Centre for Cardiovascular Research · ESUniversidad Complutense de Madrid · ESUniversity of Sheffield · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

ADAM17/TACE is a metalloproteinase responsible for the shedding of the proinflammatory cytokine TNF-α and many other cell surface proteins involved in development, cell adhesion, migration, differentiation, and proliferation. Despite the important biological function of ADAM17, the mechanisms of regulation of its metalloproteinase activity remain largely unknown. We report here that the tetraspanin CD9 and ADAM17 partially co-localize on the surface of endothelial and monocytic cells. In situ proximity ligation, co-immunoprecipitation, crosslinking, and pull-down experiments collectively demonstrate a direct association between these molecules. Functional studies reveal that treatment with CD9-specific antibodies or neoexpression of CD9 exert negative regulatory effects on ADAM17 sheddase activity. Conversely, CD9 silencing increased the activity of ADAM17 against its substrates TNF-α and ICAM-1. Taken together, our results show that CD9 associates with ADAM17 and, through this interaction, negatively regulates the sheddase activity of ADAM17.

Indexed as

ADAM17 ProteinADAM ProteinsAntigens, CDCell LineEndothelial CellsGene SilencingHumansIntercellular Adhesion Molecule-1LeukocytesMembrane GlycoproteinsTetraspanin 29Tumor Necrosis Factor-alphaADAM17 ProteinADAM17 protein, humanADAM ProteinsAntigens, CDCD9 protein, humanIntercellular Adhesion Molecule-1Membrane GlycoproteinsTetraspanin 29Tumor Necrosis Factor-alpha

Identifiers

PMID21365281
PMCPMC11115118
OpenAlexW1977323533

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.